Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Moleculin Biotech, Inc. (MBRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/13/2023 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,216 shares @ $0.5903, valued at $1.9k
Exercised 13,204 restricted stock units @ $0
07/05/2023 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $0.5788, valued at $2.1k
Exercised 14,717 restricted stock units @ $0
05/26/2023 4 Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 15,000 options to buy @ $0.62, valued at $9.3k
05/26/2023 4 Cermak Elizabeth (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 15,000 options to buy @ $0.62, valued at $9.3k
05/26/2023 4 Climaco John M (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 15,000 options to buy @ $0.62, valued at $9.3k
05/26/2023 4 CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 15,000 options to buy @ $0.62, valued at $9.3k
05/26/2023 4 George Robert E. (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 15,000 options to buy @ $0.62, valued at $9.3k
11/28/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Bought 45,000 shares @ $1.2807, valued at $57.6k
11/23/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Bought 22,500 shares @ $1.1496, valued at $25.9k
11/18/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Bought 85,213 shares @ $0.9695, valued at $82.6k
Bought 24,742 shares @ $1.0208, valued at $25.3k
07/15/2022 4/A KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $1.47, valued at $5.3k
Exercised 14,717 restricted stock units @ $0
07/15/2022 4/A KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,215 shares @ $1.68, valued at $5.4k
Exercised 13,205 restricted stock units @ $0
07/15/2022 4/A KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 225,000 options to buy @ $1.49, valued at $335.3k
Granted 225,000 restricted stock units @ $0
07/13/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,215 shares @ $1.68, valued at $5.4k
Exercised 13,205 restricted stock units @ $0
07/06/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $1.47, valued at $5.3k
Exercised 14,717 restricted stock units @ $0
06/22/2022 4 PICKER DONALD H (Chief Science Officer) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 65,000 options to buy @ $1.49, valued at $96.9k
Granted 64,667 restricted stock units @ $0
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 360,000 options to buy @ $1.49, valued at $536.4k
Granted 362,000 restricted stock units @ $0
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 George Robert E. (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 23,333 options to buy @ $1.49, valued at $34.8k
Granted 15,000 options to buy @ $1.49, valued at $22.4k
06/22/2022 4 CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 23,333 options to buy @ $1.49, valued at $34.8k
Granted 15,000 options to buy @ $1.49, valued at $22.4k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 23,333 options to buy @ $1.49, valued at $34.8k
Granted 15,000 options to buy @ $1.49, valued at $22.4k
06/21/2022 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 6,088 shares @ $1.33, valued at $8.1k
Exercised 25,000 restricted stock units @ $0
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 6,667 options to buy @ $1.38, valued at $9.2k
03/02/2022 3 Yan Joy (Director) has filed a Form 3 on Moleculin Biotech, Inc.
07/12/2021 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,215 shares @ $3.56, valued at $11.4k
Exercised 13,205 restricted stock units @ $0
07/06/2021 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Paid exercise price by delivering 3,584 shares @ $3.56, valued at $12.8k
Exercised 14,718 restricted stock units @ $0
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 PICKER DONALD H (Chief Science Officer) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 62,676 options to buy @ $3.73, valued at $233.8k
06/21/2021 4 KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 223,635 options to buy @ $3.73, valued at $834.2k
Granted 100,000 restricted stock units @ $0
06/09/2021 4 CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.
Txns: Granted 10,000 options to buy @ $3.95, valued at $39.5k
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy